Variant report
Variant | nsv1046136 |
---|---|
Chromosome Location | chr13:69051662-69070011 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs546407893 | chr13:69054642-69054643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs559683681 | chr13:69054646-69054647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs151151581 | chr13:69054653-69054654 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs533383974 | chr13:69054660-69054661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552358388 | chr13:69054698-69054699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs185884404 | chr13:69054715-69054716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs371151011 | chr13:69054845-69054846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs143119124 | chr13:69054882-69054883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs525338 | chr13:69054895-69054896 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs567587857 | chr13:69054896-69054897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs17083450 | chr13:69054903-69054904 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs553211749 | chr13:69054927-69054928 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs566918528 | chr13:69054930-69054931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs368598810 | chr13:69054935-69054936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs528903160 | chr13:69054954-69054955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs192408975 | chr13:69054956-69054957 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs200143913 | chr13:69054960-69054961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs678386 | chr13:69054995-69054996 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs145688129 | chr13:69055035-69055036 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
20 | rs575424649 | chr13:69055107-69055108 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs183847021 | chr13:69055188-69055189 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs188817527 | chr13:69055199-69055200 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs555224150 | chr13:69055206-69055207 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs191416187 | chr13:69055233-69055234 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs202080314 | chr13:69055260-69055261 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs77601439 | chr13:69055300-69055301 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs5804389 | chr13:69055301-69055302 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs374048559 | chr13:69055307-69055308 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs572964253 | chr13:69055311-69055312 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
30 | rs199998899 | chr13:69055312-69055313 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs71721281 | chr13:69055313-69055314 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs66942186 | chr13:69055316-69055317 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs398023241 | chr13:69055322-69055323 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs559998741 | chr13:69055328-69055329 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
35 | rs532196071 | chr13:69055337-69055338 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
36 | rs547280848 | chr13:69055348-69055349 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
37 | rs12585412 | chr13:69055357-69055358 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
38 | rs565594770 | chr13:69055389-69055390 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
39 | rs545909358 | chr13:69055392-69055393 | Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
40 | rs1887593 | chr13:69055410-69055411 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs114168064 | chr13:69055413-69055414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs79734166 | chr13:69055484-69055485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs568315405 | chr13:69055494-69055495 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs557637517 | chr13:69055500-69055501 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs571443324 | chr13:69055564-69055565 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs182536303 | chr13:69055591-69055592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs681086 | chr13:69055597-69055598 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs546928227 | chr13:69055624-69055625 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs566750928 | chr13:69055643-69055644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs186903351 | chr13:69055694-69055695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 17133270 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Paraganglioma | 21461997 | CNVD |
Pheochromocytoma | 21461997 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Prostate cancer | 17245344 | CNVD |
Prostate cancer | 18632612 | CNVD |
Colorectal cancer | 21586687 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Breast cancer | 21858162 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Glioblastoma multiforme | 21750150 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 17393978 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
abnormal development | 18461090 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Prostate cancer | 16461572 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal cancer | 21851588 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:69054600-69054800 | Enhancers | Left Ventricle | heart |
2 | chr13:69054600-69055000 | Enhancers | Fetal Heart | heart |
3 | chr13:69054600-69055600 | Enhancers | Pancreas | Pancrea |
4 | chr13:69054600-69056000 | Enhancers | Ovary | ovary |
5 | chr13:69055000-69055400 | Enhancers | Aorta | Aorta |
6 | chr13:69055000-69055400 | Flanking Active TSS | Fetal Heart | heart |
7 | chr13:69055000-69056200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
8 | chr13:69055400-69055600 | Enhancers | Left Ventricle | heart |
9 | chr13:69055400-69056200 | Enhancers | Fetal Heart | heart |
10 | chr13:69055600-69056000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
11 | chr13:69068000-69068400 | Enhancers | Cortex derived primary cultured neurospheres | brain |